Xue Yang
Impact in
- Pharmaceutical Science top 1%
- Advancements in Transdermal Drug Delivery
- Cancer Research top 5%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
Papers in
-
- RNA modifications and cancer 6
-
- Nanoplatforms for cancer theranostics 22
- Co-authors
- Yiqun Yu (1 shared paper)Yibin Fan (1 shared paper)Xiaofang Wu (1 shared paper)Xiaozhou Mou (17 shared papers)Xiaoyi Chen (5 shared papers)Luo‐Qin Fu (3 shared papers)Maohua Cai (3 shared papers)Huipeng Li (3 shared papers)
- Journals
- Oncotarget (5 papers)Frontiers in Immunology (4 papers)Oncology Reports (4 papers)Frontiers in Bioengineering and Biotechnology (4 papers)Tumor Biology (4 papers)
- Partner nations
- ChinaUnited StatesSouth Korea
In The Last Decade
Xue Yang
151 papers receiving 3.4k citations
Xue Yang's Hit Papers
Peers
Comparison fields: 5 of 150
- Pharmaceutical Science 265
- Cancer Research 506
- Biomaterials 337
- Biological Psychiatry 45
- Molecular Medicine 90
Countries citing papers authored by Xue Yang
This map shows the geographic impact of Xue Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xue Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xue Yang more than expected).
Fields of papers citing papers by Xue Yang
This network shows the impact of papers produced by Xue Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xue Yang. The network helps show where Xue Yang may publish in the future.
Co-authors
The 25 scholars most cited alongside Xue Yang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 160 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Enhancing Permeation of Drug Molecules Across the Skin via Delivery in Nanocarriers: Novel Strategies for Effective Transdermal Applications Hit paper breakdown → | 2021 | 324 |
| 2 | 2020 | 166 | |
| 3 | 2019 | 162 | |
| 4 | 2018 | 136 | |
| 5 | 2021 | 117 | |
| 6 | 2011 | 95 | |
| 7 | 2021 | 92 | |
| 8 | 2021 | 84 | |
| 9 | 2015 | 82 | |
| 10 | 2016 | 72 | |
| 11 | 2017 | 68 | |
| 12 | 2018 | 62 | |
| 13 | 2019 | 59 | |
| 14 | 2018 | 59 | |
| 15 | 2014 | 49 | |
| 16 | 2020 | 47 | |
| 17 | 2018 | 47 | |
| 18 | 2015 | 47 | |
| 19 | 2018 | 46 | |
| 20 | 2011 | 46 |
About Xue Yang
Xue Yang is a scholar working on Molecular Biology, Biomedical Engineering, Oncology, Cancer Research and Immunology, having authored 160 papers that have together received 3.4k indexed citations. Recurring topics across this work include Nanoplatforms for cancer theranostics (22 papers), Cancer-related molecular mechanisms research (10 papers), Immune cells in cancer (10 papers), Nanoparticle-Based Drug Delivery (8 papers), MicroRNA in disease regulation (8 papers), Photodynamic Therapy Research Studies (6 papers), Virus-based gene therapy research (6 papers) and RNA modifications and cancer (6 papers). The work is most often cited by research in Pharmaceutical Science (265 citations), Cancer Research (506 citations), Biomaterials (337 citations), Biological Psychiatry (45 citations) and Molecular Medicine (90 citations). Xue Yang has collaborated with scholars based in China, United States and South Korea. Frequent co-authors include Yiqun Yu, Yibin Fan, Xiaofang Wu, Xiaozhou Mou, Xiaoyi Chen, Luo‐Qin Fu, Maohua Cai, Huipeng Li, Minjie Sun and Jing Yu. Their work appears in journals such as Oncotarget, Frontiers in Immunology, Oncology Reports, Frontiers in Bioengineering and Biotechnology and Tumor Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.